Bio-Rad Laboratories, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $435.6M | $2.19B | $331.6M |
| FY2014 | $435.7M | $2.18B | $413.3M |
| FY2015 | $433.9M | $2.49B | $457.5M |
| FY2016 | $434.2M | $2.58B | $456.3M |
| FY2017 | $434.6M | $2.93B | $383.8M |
| FY2018 | $438.9M | $4.02B | $431.5M |
| FY2019 | $13.6M | $5.76B | $660.7M |
| FY2020 | $12.3M | $9.89B | $662.2M |
| FY2021 | $10.5M | $13.69B | $470.8M |
| FY2022 | $1.20B | $9.62B | $434.2M |